Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study (Q57244516)
Jump to navigation
Jump to search
scientific article published in The Lancet
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study |
scientific article published in The Lancet |
Statements
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions (English)
B Rzany
J P Kelly
A Auquier